Protagenic Therapeutics, Inc.
Balance Sheet
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $362.5K | $399.7K | $3.1M | $3.3K | $22.7K |
| Accounts Receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $696.3K | $1.8M | $3.2M | $3.3K | $245.0K |
| Property, Plant & Equipment | $611 | $1.0K | $1.1K | $1.6K | $1.0K |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $696.9K | $1.8M | $3.2M | $11.1K | $246.0K |
| Liabilities | |||||
| Accounts Payable | $231.7K | $135.9K | $168.0K | $279.3K | $138.0K |
| Total Current Liabilities | $907.8K | $561.7K | $684.9K | $678.4K | $141.0K |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $907.8K | $561.7K | $684.9K | $704.0K | $316.0K |
| Stockholders' Equity | |||||
| Retained Earnings | $-13.4M | $-10.8M | $-8.6M | $-6.3M | $-1.1M |
| Total Stockholders' Equity | $-210.9K | $1.2M | $2.5M | $-667.2K | $-21.0K |